Austar Lifesciences Ltd. (HK:6118) has released an update.
Austar Lifesciences Ltd. has successfully passed all resolutions during its Annual General Meeting on May 31, 2024, including the re-election of directors and the granting of general mandates for share issuance and repurchase. Shareholders unanimously voted in favor of the proposed resolutions, with the company achieving 100% approval on most items, reflecting strong shareholder support for the current management and strategic direction.
For further insights into HK:6118 stock, check out TipRanks’ Stock Analysis page.
